|
|
|
|
This Food Found Linked to Pancreatic Cancer
People who drink two or more sweetened soft drinks a week have a much higher risk of pancreatic cancer, an unusual but deadly cancer, researchers reported on Monday."The high levels of sugar in soft drinks may be increasing the level of...
|
|
|
Soft drinks could boost pancreatic cancer risk
MONDAY, Feb.8 (HealthDay News) -- People who down two or more soft drinks a week may have double the risk of developing deadly pancreatic cancer, compared to non-soda drinkers, new research suggests. But the overall number of people developing...
|
|
|
Soft drinks increase risk of developing pancreatic cancer
Consuming two or more soft drinks per week increased the risk of developing pancreatic cancer by nearly two-fold compared with individuals who did not consume soft drinks, according to a report in Cancer Epidemiology, Biomarkers &...
|
|
|
Sweet drinks greatly up pancreatic cancer risk
People who drink two or more sweetened soft drinks a week have a much higher risk of pancreatic cancer, an unusual but deadly cancer, researchers reported on Monday.People who drank mostly fruit juice instead of sodas did not have the same...
|
|
|
Sweet drinks greatly up pancreatic cancer risk
People who drink two or more sweetened soft drinks a week have a much higher risk of pancreatic cancer, an unusual but deadly cancer, researchers reported on Monday.People who drank mostly fruit juice instead of sodas did not have the same...
|
|
|
Exploratory data presented for Active Biotech's ANYARA project - ...
Company: Active Biotech AB (ATVBF) Active Biotech AB (NASDAQ OMX Nordic: ACTI) has presented results from exploratory preclinical studies at the Keystone Symposia "Molecular and Cellular Biology of Immune Escape in Cancer" held in Keystone, Colorado, USA,...
|
|
|
Exploratory data presented for Active Biotech's ANYARA project
Active Biotech AB (NASDAQ OMX Nordic: ACTI) has presented results from exploratory preclinical studies at the Keystone Symposia "Molecular and Cellular Biology of Immune Escape in Cancer" held in Keystone, Colorado, USA, February 7-12.The complete...
|
|
|
Phase I Trial Commences Treating Patients with Pancreatic and Colorectal Cancer Using Novel Monoclonal Antibod
GREAT NECK, N.Y.(BUSINESS WIRE) Neogenix Oncology, Inc.(Neogenix) announced today that the Johns Hopkins Hospital has initiated a Phase I trial with the company's first therapeutic antibody, NPC-1C, in patients with late stage pancreatic or colorectal ...
|
|
|
::: Phase I Trial Commences Treating Patients with Pancreatic and Colorectal Cancer Using Novel Monoclonal Ant
GREAT NECK, N.Y.--(BUSINESS WIRE)--Neogenix Oncology, Inc.(Neogenix) announced today that the Johns Hopkins Hospital has initiated a Phase I trial with the company's first therapeutic antibody, NPC-1C, in patients with late stage pancreatic or...
|
|
|
Sugary soft drinks linked to pancreatic cancer: study
People who drink at least two sugary sodas a week have an increased risk of developing cancer of the pancreas, and researchers suspect the culprit is sugar, a new study shows.Analyses of data collected on 60,524 Singapore Chinese adults showed that...
|
|
|
Sugary soft drinks linked to pancreatic cancer
People who drink at least two sugary sodas a week have an increased risk of developing cancer of the pancreas, and researchers suspect the culprit is sugar, a new study shows.Analyses of data collected on 60,524 Singapore Chinese adults showed that...
|
|
|
::: BSD Medical Reports Initiation of a Phase III Study on Pancreatic Cancer Using the BSD-2000 Hyperthermia S
SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) reports initiation of a randomized, multicenter Phase III clinical study using the BSD-2000 Hyperthermia System in combination with chemotherapy for the treatment of pancreatic ...
|
|
|
Exploratory data presented for Active Biotech's ANYARA project
LUND, SWEDEN -- (MARKET WIRE) -- 02/10/10 -- Active Biotech AB (NASDAQ OMX Nordic: ACTI) has presented results from exploratory preclinical studies at the Keystone Symposia 'Molecular and Cellular Biology of Immune Escape in Cancer' held in Keystone,...
|
|
|
Exploratory data presented for Active Biotech's ANYARA project
Active Biotech AB (NASDAQ OMX Nordic: ACTI) has presented results from exploratory preclinical studies at the Keystone Symposia 'Molecular and Cellular Biology of Immune Escape in Cancer' held in Keystone, Colorado, USA, February 7-12.The complete...
|
|
|
Exploratory data presented for Active Biotech's ANYARA project
- Active Biotech AB (NASDAQ OMX Nordic:ACTI) has presented results from exploratory preclinical studies at the Keystone Symposia "Molecular and Cellular Biology of Immune Escape in Cancer" held in Keystone, Colorado, USA, February 7-12.The complete...
|
|
|
Exploratory data presented for Active Biotech's ANYARA project
(MARKETWIRE via COMTEX) ----Active Biotech AB (NASDAQ OMX Nordic: ACTI) has presented results from exploratory preclinical studies at the Keystone Symposia "Molecular and Cellular Biology of Immune Escape in Cancer" held in Keystone, Colorado, USA,...
|
|
|
Exploratory data presented for Active Biotech's ANYARA project
(MARKETWIRE via COMTEX News Network) -- Active Biotech AB (NASDAQ OMX Nordic: ACTI) has presented results from exploratory preclinical studies at the Keystone Symposia "Molecular and Cellular Biology of Immune Escape in Cancer" held in Keystone, Colorado,...
|
|
|
Exploratory data presented for Active Biotech's ANYARA project
LUND, SWEDEN -- (Marketwire) -- 02/10/10 -- Active Biotech AB (NASDAQ OMX Nordic: ACTI) has presented results from exploratory preclinical studies at the Keystone Symposia "Molecular and Cellular Biology of Immune Escape in Cancer" held in Keystone, The...
|
|
|
Exploratory data presented for Active Biotech's ANYARA project
LUND, SWEDEN--(Marketwire - 02/10/10) - Active Biotech AB (NASDAQ OMX Nordic: ACTI) has presented results from exploratory preclinical studies at the Keystone Symposia 'Molecular and Cellular Biology of Immune Escape in Cancer' held in Keystone, Colorado,...
|
|
|
Exploratory data presented for Active Biotech's ANYARA project
LUND, SWEDEN -- (Marketwire) -- 02/10/10 -- Active Biotech AB (NASDAQ OMX Nordic: ACTI) has presented results from exploratory preclinical studies at the Keystone Symposia "Molecular and Cellular Biology of Immune Escape in Cancer" held in Keystone,...
|
|
|
Exploratory data presented for Active Biotechs ANYARA project
LUND, SWEDEN -- (MARKET WIRE) -- 02/10/10 -- Active Biotech AB (NASDAQ OMX Nordic: ACTI) has presented results from exploratory preclinical studies at the Keystone Symposia "Molecular and Cellular Biology of Immune Escape in Cancer" held in Keystone,...
|
|
|
Exploratory data presented for Active Biotechs ANYARA project
- Active Biotech AB (NASDAQ OMX Nordic:ACTI) has presented results from exploratory preclinical studies at the Keystone Symposia "Molecular and Cellular Biology of Immune Escape in Cancer" held in Keystone, Colorado, USA, February 7-12.The complete...
|
|
|
With pancreatic cancer, age factors into familial risk
People with a family member who had pancreatic cancer before age 50 face a greatly increased risk for the disease, a new study has found.Researchers already knew that people with several relatives diagnosed with pancreatic cancer were...
|
|
|
Fizzy drinks may increase risk of cancer
Next 1 2 Washington - People who drink at least two sugary sodas a week have an increased risk of developing cancer of the pancreas, and researchers suspect the culprit is sugar, a study published on Monday shows.Analyses of data collected on 60 524...
|
|
|
Active Biotech : Exploratory data presented for Active Biotech's...
- Active Biotech AB (NASDAQ OMX Nordic:ACTI) has presented results from exploratory preclinical studies at the Keystone Symposia "Molecular and Cellular Biology of Immune Escape in Cancer" held in Keystone, Colorado, USA, February 7-12.The complete...
|
